Management of Post-Myocardial Infarction Patients with Left Ventricular Systolic Dysfunction

Mihai Gheorghiade*, Gregg C. Fonarow

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


After a myocardial infarction (MI), patients are at risk for reinfarction, heart failure (HF), and sudden death. This risk is much higher in patients with left ventricular systolic dysfunction (LVSD). Although post-MI patients with LVSD have an even greater risk of mortality and morbidity, they had been generally excluded from clinical trials. This article reviews recent clinical trials that included post-MI patients with LVSD with or without signs and symptoms of HF. These trials have defined the benefits of pharmacologic management and device therapy in patients who survive an MI in the presence of LVSD.

Original languageEnglish (US)
Pages (from-to)109-120
Number of pages12
JournalAmerican Journal of Medicine
Issue number2
StatePublished - Feb 1 2007


  • Neurohormonal antagonists
  • Post-MI management
  • Systolic dysfunction

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Management of Post-Myocardial Infarction Patients with Left Ventricular Systolic Dysfunction'. Together they form a unique fingerprint.

Cite this